Orchestra BioMed Holdings, Inc
Advertisement
Orchestra BioMed Holdings, Inc is a biomedical innovation company based in New Hope, PA, dedicated to bringing medical innovations to life. They accelerate high-impact technologies to patients through risk-reward sharing partnerships with leading medical device companies, focusing on forging strategic collaborations to drive successful global commercialization of their innovative therapeutic product candidates.
Their late-stage flagship technologies, BackBeat Cardiac Neuromodulation Therapy (BackBeat CNT) and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB), aim to address significant unmet needs associated with the treatment of hypertension and atherosclerotic artery disease, respectively. BackBeat CNT is an investigational bioelectronic treatment designed to drive an immediate and persistent reduction in blood pressure, while Virtue SAB is a drug-device combination product candidate for artery disease treatment, delivering a proprietary extended-release formulation of sirolimus during balloon angioplasty.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement